The 5th edition of the Gamma Delta T Cell Therapies Summit is set to explore the unique biology of gamma delta T cells, offering insights into targeted interventions and engineering techniques to advance therapeutic development. This summit aims to enhance cross-functional teams' skills in discovery, translation, and clinical development, facilitating the translation of research into effective clinical strategies for IND submissions. Sessions will focus on optimizing clinical trial design for better targeting of the tumor microenvironment (TME), exploring innovative engineering approaches, and navigating regulatory challenges. Collaborations with leading companies like IN8Bio, Adicet Bio, and Takeda will highlight translational lessons from therapies harnessing gamma delta T cell biology.

 [Read on gamma-delta-t-therapies.com](https://gamma-delta-t-therapies.com/take-part/register/)

In 2023, the Nobel Prize honored mRNA technology, igniting a surge of advancements and clinical prospects. The 4th mRNA-Based Therapeutics Summit stands as the foremost conference, showcasing insights from industry leaders like CureVac, Moderna, BioNTech, and Sanofi. With 400+ experts and 65+ speakers, including FDA and EMA representatives, attendees delve into personalized sessions across discovery, translation, clinical development, and manufacturing. Interactive roundtables, a CEOs' Panel Discussion, and focused days on regulatory affairs and mRNA delivery enhance networking opportunities. Scheduled from July 29-31, 2024, this summit promises unparalleled access to the latest in mRNA therapeutics. 

[Read on mrnabased-therapeutics.com](https://mrnabased-therapeutics.com/)

The 1777th International Conference on Science, Health, and Medicine (ICSHM) is slated to occur on July 28th-29th, 2024, in Philadelphia, USA. Organized by The International Society for Engineers and Researchers (ISER), ICSHM aims to provide a premier platform for global academicians, researchers, engineers, and students to disseminate their research findings and interact with esteemed experts in the field. By facilitating in-person exchanges, the conference seeks to foster collaborations and establish international linkages for future endeavors. With a focus on cutting-edge scientific fields, ICSHM anticipates significant contributions to the global knowledge base. The event will feature invited lectures and recognize outstanding papers with Best Paper Awards.

Read on iser.co

The 2024 Research International Conference on Medical, Medicine, and Health Science (RICMMHS-2024) is scheduled to take place in New York, USA, from July 26th to 27th, 2024. RICMMHS-2024 aims to convene eminent academic scientists, researchers, and scholars to exchange insights and findings on various facets of Medical, Medicine, and Health Sciences. This conference serves as a prestigious interdisciplinary platform for participants to showcase recent innovations, discuss emerging trends, and address practical challenges within these fields. Attendees will have the opportunity to engage in discussions and share their experiences, contributing to the advancement of Medical, Medicine, and Health Sciences.

Read on researchconferences.in

The ABIM Internal Medicine Board Review Course, hosted by Tulane University Health Sciences Center and A-Cross Medicine Reviews, offers a comprehensive platform for physicians preparing for initial certification or Maintenance of Certification (MOC) examinations. Held in Chicago, this program covers diverse internal medicine topics, including hypertension, diabetes management, and ethical dilemmas, using evidence-based guidelines. Aimed at enhancing clinical practice, the conference focuses on core knowledge in internal medicine, facilitates problem-solving strategies for test-taking, and supports the implementation of current clinical guidelines. Participants can earn AMA PRA Category 1 Credit™ and MOC points, ensuring readiness for certification exams while adhering to ACCME guidelines and ABIM blueprints.

 [Read on www.a-crossmedicinereviews.com](https://a-crossmedicinereviews.net/)

The Women's Health Therapeutics and Diagnostics Summit, scheduled from July 23rd to 25th, 2024, addresses the historical neglect and underfunding of women's health, aiming to drive innovation and progress in the field. Recent investments in women's health biotech and pharma highlight a renewed focus on addressing female-specific health challenges. Industry pioneers like Freya Bioscience and Heranova Lifesciences have secured substantial funding for clinical solutions. This summit provides a vital platform for collaboration among biotech and biopharma leaders to advance treatments for conditions like endometriosis, bacterial vaginosis, infertility, and menopause. Join over 60 experts in Boston to propel the revolution in women's healthcare. 

[Read on womens-healthsummit.com](https://womens-healthsummit.com/)

International Conference on Science, Health and Medicine (ICSHM) is a prestigious event organized with a motivation to provide an excellent international platform for the academicians, researchers, engineers, industrial participants and budding students around the world to SHARE their research findings with the global experts. ICSHM 2023 will be held in Miami, United States of America on 23rd - 24th July, 2024.
The key intention of ICSHM is to provide opportunity for the global participants to share their ideas and experience in person with their peers expected to join from different parts on the world. 

Read on iser.co

The 4th Annual Induced Proximity-Based Drug Discovery Summit convenes from July 23rd to 25th, 2024, addressing the burgeoning field beyond PROTACs in protein stabilization, modulation, and post-translational modification. Distinguished biopharma leaders converge to explore untapped opportunities and challenges in developing selective and potent small molecules and biologics. This established forum offers data-driven presentations, technical discussions, and interactive sessions, facilitating knowledge exchange among 100+ induced proximity experts. Delving into diverse fields within and beyond protein degradation, the summit serves as a crucial platform for validating novel mechanisms of action and accessing diverse chemical matter in drug discovery endeavors.

 [Read on induced-proximity-summit.com](https://induced-proximity-summit.com/)

The 2nd ADC Toxicity Summit, scheduled from July 23rd to July 25th, 2024, presents a crucial opportunity to address the persistent challenge of toxicities hindering the progression of antibody-drug conjugates (ADCs) to clinical use. With an increasing number of companies entering the ADC arena and heightened competition, understanding translational challenges and off-target toxicities becomes paramount. This summit brings together over 80 colleagues from leading pharmaceutical companies like Pfizer, Merck, ImmunoGen, and others to discuss shared challenges in ADC toxicities, from in vitro to clinical stages. Experts will unveil novel toxicity data, discuss optimal in vivo models, explore biomarker utilization, and introduce innovative strategies to enhance ADC therapeutic index. This event aims to unite the foremost minds in ADC toxicology to offer actionable insights for predicting and mitigating toxicities, driving ADC development forward to address unmet medical needs effectively.

 [Read on adc-toxicity.com](https://adc-toxicity.com/take-part/register/)

The 12th Annual Tumor Models Boston Summit is held on 23-24 July 2024 in Boston. In the wake of the FDA Modernization Act and translational rates of cancer drugs into the clinic at just 20%, it is critical that oncology scientists invest in more translational and predictive models to de-risk the validation of novel targets, predict therapeutic response, and support biomarker discovery. The 12th Annual Tumor Models Boston Summit is the only industry-led meeting uniting 200+ industry experts from pharma, biotech, academic KOLs and preclinical CROs to delve into the latest case studies in leveraging PDX models, genetically engineered mouse models, advanced 3D in vitro models and more. Join industry leaders developing teams in preclinical, translational, pharmacology, discovery, pharmacodynamics, toxicity and biology to optimize and implement more translatable oncology models. 

[Read on tumor-models.com](https://tumor-models.com/take-part/register/)